| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. | CHIEF FINANCIAL OFFICER | Ordinary Shares | 1,319,876 | $9,023,464 | $6.84 | 01 Jul 2025 | Direct |
| Structure Therapeutics Inc. | CHIEF FINANCIAL OFFICER | American Depositary Shares | 2,946 | $64,592 | $30.54 | 21 May 2025 | Direct |
| Structure Therapeutics Inc. | CHIEF FINANCIAL OFFICER | Ordinary Shares | 1,554,586 | 15 Mar 2025 | Indirect | ||
| Structure Therapeutics Inc. | CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | 413,445 | 15 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | 15 Mar 2025 | 4 | $0 | 4 | CHIEF FINANCIAL OFFICER | 18 Mar 2025, 20:45 |
| GPCR | Structure Therapeutics Inc. | 01 Mar 2025 | 4 | -$95,489 | 4 | CHIEF FINANCIAL OFFICER | 03 Jul 2025, 17:15 |
| GPCR | Structure Therapeutics Inc. | 15 Mar 2024 | 1 | $0 | 4/A | CHIEF FINANCIAL OFFICER | 20 Mar 2024, 19:37 |
| GPCR | Structure Therapeutics Inc. | 15 Mar 2024 | 2 | $0 | 4 | CHIEF FINANCIAL OFFICER | 19 Mar 2024, 16:44 |
| GPCR | Structure Therapeutics Inc. | 07 Feb 2023 | 1 | +$9,000 | 4 | Chief Financial Officer | 09 Feb 2023, 18:01 |
| GPCR | Structure Therapeutics Inc. | 02 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 06 Feb 2023, 15:47 |
| GPCR | Structure Therapeutics Inc. | 02 Feb 2023 | 0 | $0 | 3 | Chief Financial Officer | 02 Feb 2023, 17:09 |